This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Tuesday's Small-Cap Winners & Losers

O.I. Corp (OICO) sank on news that it will conduct an internal review of its historical stock-option grants. During the probe, the Texas-based maker of chemical-analysis products will halt its stock buyback program. President, Chairman and Chief Executive William Botts will be put on voluntary paid leave along with VP and Corporate Secretary Jane Smith. Four high-level employees and board members are to assume the vacated roles. O.I. also warned that it might be late with its year-end report if the probe uncovers "significant" issues. Shares were falling $1.02, or 9.2%, to $10.13.

Health care company Radiation Therapy Services (RTSX) cut its earnings guidance for the fourth quarter to 30 cents a share, down from November's estimated range of 36 cents to 38 cents. The new total includes several items, the Fort Myers, Fla., company says, without which income would have totaled 36 cents. The revenue forecast was revised to $76 million to $78 million, up from $74 million to $77 million previously. Analysts are calling for $76.9 million on the top line. Shares were down $2.97, or 9.1%, to $29.71.

Double Eagle Petroleum (DBLE) fell after it reported "poor reservoir quality rock" in a Christmas Meadows Prospect well in northeastern Utah. The Casper, Wyo., company operates and currently owns roughly a quarter of the well, with its working interest soon due to increase to more than 30%. Shares were losing $1.51, or 6.5%, to $21.80.

Hi/fn (HIFN) was lower after the company widened its loss to $2.7 million, or 19 cents a share, in the quarter ended Dec. 31. The year-ago loss totaled $1.7 million, or 12 cents a share. Sales shrank 13% to $9.3 million. Shares were down 38 cents, or 6.7%, to $5.27.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
DBLE $1.19 0.85%
NICH $0.00 0.00%
TWIN $13.25 0.00%
AAPL $93.74 0.00%
FB $117.58 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs